what glp 1 is serena williams taking Shares Her GLP-1 Weight Loss Journey With Company Ro Serena Williams Opens Up About

Unlike the other antidiabetic treatment options, incretin mimetics do not induce hypoglycemia and either cause weight loss or or no change in weight

Search snippets, old screenshots, and third-party references may become outdated

Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72

population is estimated to be obese, and another 31 percent are overweight, the study noted

Until brands figure that out, topical GLP-1 skincare is more concept than reality

Additionally, gastrointestinal side effects are common